Buscopan Reflux 14 Tablets 20mg,Buscopan Reflusso 14 Compresse 20mg,BOEHRINGER INGELHEIM IT.SPA

“ACTIVE ingredients: Each enteric-coated tablet contains pantoprazole 20 mg in the amount of pan toprazolo sodium sesquidrato 22.6 mg. Excipients: Tablet core: mannitol, sodium carbonate anhydrous, sodium carbossimet ilamido (type a), methacrylic acid – ethyl acrylate copolymer (Eudragit AND A LITTLE), calcium stearate, opadry white OY-D-7233 (hypromellose, titanium dioxide E171, Macrogol 400 , sodium lauryl sulfate). Coating t kollicoat MAE 30 DP, light yellow, consisting of: methacrylic acid – a copolymer of ethyl acrylate with propylene glycol; iron oxide gi in (E172), titanium dioxide (E171), talc, purified water.
INDICATIONS: Short-term treatment of reflux symptoms (eg, heartburn, acid reflux) in adults.
CONTRAINDICATIONS/EFF.SECONDARY: Hypersensitivity to the active substance or to any of the excipients. Simultaneously taken with atazanavir.
DOSAGE: The recommended dose is 20 mg pantoprazole (one tablet) per day or. It may be necessary to take the tablets for 2-3 days with secutivi to achieve improvement in symptoms. When the rays blurred the complete healing of the symptoms, the treatment must be I know spent. Treatment should not exceed 4 weeks without consulting a doctor. If within 2 weeks of continuous treatment you do not notice any improvement in symptoms, the patient should consult a doctor. There is no need for dose adjustment in elderly patients or patients with impaired renal or hepatic function. Use is not recommended in children and adolescents under 18 years of age due to sufficient data on safety and effectiveness. Gas troresistenti tablets should not be chewed or crushed, and should rather be swallowed whole without chewing before eating.
STORAGE: This medicine does not require special storage conditions.
Special INSTRUCTIONS: Patients should be instructed to consult a physician if: they have involuntary weight loss, anemia, gastric bleeding, dysphagia, persistent vomiting or vomiting of blood, given that medication may relieve symptoms and delay the diagnosis of a serious condition. In these cases, the form of malignant na should be excluded; – have had previous gastric ulcers or gastrointestinal surgery; – continue symptomatic treatment for indigestion or heartburn for 4 weeks or more; – they have jaundice, liver compromition, or liver disease; – have any other serious pathology that jeopardizes general well-being; – more than 55 an ni with symptoms, new or recently changed. Patients with chronic symptoms associated with indigestion or heartburn should consult a doctor at regular intervals. In particular, patients 5 years of age or older who are taking any over-the-counter medications daily for indigestion or heartburn should tell their pharmacist or co. Patients should not take any other proton pump inib itore or H2 antagonists at the same time. Patients who are scheduled to undergo endoscopy or a breath test (UBT) should consult a doctor before taking this medication. Patients should and ssi are warned that the tablets are not intended to give you instant relief. Patients may begin to experience better symptoms after about one day of treatment; pantoprazole, m, a, may need to be taken for 7 days to achieve complete control of heartburn. Patients should not take panto praz as a preventive medicine. Reducing the acidity of gastric juice, you should ta for some reason, including proton pump inhibitors – increases the amount of gastric juice for bacteria normally present in the waste to the gastrointestinal tract. Treatment with medicinal foods that reduce acidity results in a slight increase in the risk of infections such as Salmonella, Campylobacter, or C. difficile.
INTERACTIONS: The product may reduce the absorption of active ingredients, including bioavailability dependent on gastric pH (for example, ketoconazole). And it has been proven that concomitant administration of atazanavir 300 mg/ritonavir 100 mg with omeprazole (40 mg once daily) or atazanavir 400 mg lansoprazole (60 mg in a single dose) in healthy volunteers results in a significant decrease in bioavailability’ at anavir. Absorption of atazanavir is pH-dependent. So, razor pants should not be co-administered with atazanavir. Pantoprazole is metabolized in the liver by the enzyme system c itocromo P450. It cannot be excluded that pantoprazole interacts with other substances metabolized through the same coenzyme system. However, no clinically significant interactions have been observed in specific tests with carbamazepine, caffeine, diazepam, diclofen AC, digoxin, ethanol, glibenclamide, metoprolol, naproxen, nifedi pina, phenytoin, piroxicam, theophylline, and the oral contraceptives count constants levonorgestrel and ethinylest.”